13-valent pneumococcal vaccine: all 128 studies that test it
Page 2 of 2. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Baby Vaccine Study (Sched3)CompletedNCT02482636Phase 2
- The Effect of Previous Pneumococcal Immunization on the Immune Response of Patients With Severe CKD to Prevnar 13CompletedNCT02370069Phase 4
- Immunogenicity Study of an Anti-pneumococcal Vaccination Strategy in Patients With Sickle Cells DiseaseCompletedNCT02274415Phase 2
- Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBDTerminatedNCT02255227Phase 2
- Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 YearsCompletedNCT02215863Phase 4
- Community Acquired Pneumonia: Outcome, Quality of Life and Immune StatusCompletedNCT02141009Phase 4
- Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV AdultsCompletedNCT02123433Phase 3
- A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' AssaysCompletedNCT02072525Phase 4
- Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, VietnamCompletedNCT01953510Phase 2/3
- Pneumococcal Vaccination of Crohn PatientsCompletedNCT01947010Phase 4
- Protection Against Pneumococcal Infection in Children With T1DMCompletedNCT01939522Phase 4
- PCV13 + Hepatitis a Vaccine for AdultsCompletedNCT01926860Phase 4
- Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel DiseaseCompletedNCT01908283Phase 4
- Pneumococcal Vaccine in Untreated CLL PatientsCompletedNCT01892618Phase 3
- PNEUMOCELL - Conjugated Pneumococcal Vaccination in Patients With Immunoglobulin G-deficiencyCompletedNCT01847781Phase 2
- B Memory Cell Response to Vaccination With the 13-valent Pneumococcal Conjugate Vaccine in Asplenic IndividualsStatus unknownNCT01846923Phase 4
- Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant PatientsCompletedNCT01781871Phase 4
- Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of LifeCompletedNCT01735084Phase 4
- A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In ChinaCompletedNCT01692886Phase 3
- Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean ChildrenStatus unknownNCT01619462Phase 3
- Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina FasoCompletedNCT01577771Phase 4
- A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese SubjectsCompletedNCT01531322Phase 1
- Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT)Active, not recruitingNCT01527591Not applicable
- An Alternative Booster Vaccine Against Meningitis and Ear InfectionsCompletedNCT01443416Phase 3
- Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant WomenWithdrawnNCT01443117Phase 2
- Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal VaccinesCompletedNCT01432158Phase 3
- 13 Valent Pneumococcal Conjugate Vaccine - Follow-on StudyCompletedNCT01095471Phase 4
- Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Elderly SubjectsCompletedNCT00269672Phase 2